Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for seven consecutive weeks since Elon Musk joined President Donald Trump’s administration.
The TSLA stock was up close to 5% on Tuesday. In the past one month, the stock has gone down around 30%. Wedbush Securities maintained its “outperform” rating on Tesla stock, with a price target of $550.
Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on Tesla.
Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to clients and investors on Friday, March 7th. Wedbush analyst R. Driscoll expects that the company will earn $0.
At a time when sentiment in the stock is at its most vulnerable in months, Taneja deliberately chose to cash in more of his shares.
Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C.
Stock analysts at Wedbush reduced their Q1 2025 EPS estimates for shares of Ready Capital in a research report issued on Tuesday, March 4th. Wedbush analyst J. Mccanless now expects that the real estate investment trust will post earnings of $0.
To support the transformation of its business in Europe and increase long-term competitiveness, Ford will fund the plan for its German subsidiary.
Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI."